Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma

7 Jan 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35008004
DOI: 10.1016/j.intimp.2021.108399

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade gliomaPMID 35008004Read ↗

Prognostic significance of MEOX2 in gliomasSemantic proximity Read ↗

DNA Methylation, Histone Modifications, and Signal Transduction Pathways: A Close Relationship in Malignant Gliomas PathophysiologySemantic proximity Read ↗

The epigenetic dysfunction underlying malignant glioma pathogenesisSemantic proximity Read ↗

Identification of an epigenetic prognostic signature for patients with lower‐grade gliomasSemantic proximity Read ↗

Integrated Analysis Identifies MEOX2 as a Malignant Driver and Prognostic Biomarker in Brain GliomaSemantic proximity Read ↗

Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survivalSemantic proximity Read ↗

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma.Semantic proximity Read ↗

SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.Semantic proximity Read ↗

Epigenetic dysregulation in glioma.Semantic proximity Read ↗

MRC2 overexpression combined with intronic hypomethylation: potential predictors for gliomaSemantic proximity Read ↗

Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem CellsSemantic proximity Read ↗

Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.